Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial
Open Access
- 29 February 2024
- journal article
- research article
- Published by Elsevier in The Lancet Microbe
- Vol. 5 (4) , e355-e365
Abstract
No abstract availableKeywords
Funding Information
- Esperion Therapeutics
- Vetenskapsrådet (2022-06725)
This publication has 25 references indexed in Scilit:
- Effectiveness of antimicrobial stewardship interventions on early switch from intravenous-to-oral antimicrobials in hospitalized adults: A systematic reviewAmerican Journal of Infection Control, 2022
- Impact of antibiotics on the human microbiome and consequences for host healthMicrobiologyopen, 2022
- Spare and repair the gut microbiota from antibiotic-induced dysbiosis: state-of-the-artDrug Discovery Today, 2021
- Tebipenem pivoxil hydrobromide—No PICC, no problem!Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021
- Human gut microbiota/microbiome in health and diseases: a reviewAntonie van Leeuwenhoek, 2020
- Immune-Microbiota Interplay and Colonization Resistance in InfectionMolecular Cell, 2020
- Cost minimization analysis on IV to oral conversion of antimicrobial agent by the clinical pharmacist interventionClinical Epidemiology and Global Health, 2019
- Pediatric community-acquired pneumonia treated with a three-day course of tebipenem pivoxilJournal of Infection and Chemotherapy, 2017
- Human gut microbiota: does diet matter?Proceedings of the Nutrition Society, 2014
- Diversity, stability and resilience of the human gut microbiotaNature, 2012